Drug interactions in infectious diseases : (Record no. 65596)

MARC details
000 -LEADER
fixed length control field 02029nam a22002417a 4500
952 ## - LOCATION AND ITEM INFORMATION (KOHA)
Withdrawn status
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200610b2018 ||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783319724157
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.7045 PAI-M
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Pai, Manjunath P
245 ## - TITLE STATEMENT
Title Drug interactions in infectious diseases :
Remainder of title antimicrobial drug /
Statement of responsibility, etc. Manjunath P. Pai...[et.al.,]
250 ## - EDITION STATEMENT
Edition statement 4th ed.,
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. India
Name of publisher, distributor, etc. Human Press
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 565 p.
365 ## - TRADE PRICE
Price type code EU
Price amount 169.99.
500 ## - GENERAL NOTE
General note The 4th edition of Drug Interactions in Infectious Diseases is being split into two separate volumes – “Mechanisms and Models of Drug Interactions” and “Antimicrobial Drug Interactions”.<br/><br/>This volume, “Antimicrobial Drug Interactions,” delivers a quick clinical resource that distills relevant drug interactions by antimicrobial drug class. The book provides informative tables on specific drug-drug interactions that include the degree and severity of the expected interaction. A mechanistic basis for drug-drug interactions is also provided to link observed interactions to pharmacologic characteristics of key drug classes. This complete resource is organized by major antibacterial, antimycobacterial, antiviral, antifungal, antimalarial, and antiprotozoal class. In line with current innovations in antimicrobial drug development, a distinct chapter on the pharmacologic management of drug interactions in hepatitis B virus (HBV) and hepatitis C virus (HCV)-related infections is included. Two new chapters are dedicated to the management of human immunodeficiency virus (HIV) drug-drug interactions given the breadth of antiretroviral class-specific effects. This comprehensive review of known drug interactions and strategies to manage them is an invaluable resource to all health care practitioners.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Communicable diseases
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug interactions
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Anti-infective agents
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical technology
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacy
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Anti-infective agents--Side effects
Holdings
Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Cost, normal purchase price Full call number Barcode Date last seen Price effective from Koha item type
  Dewey Decimal Classification     610 BITS Pilani Hyderabad BITS Pilani Hyderabad General Stack (For lending) 10/06/2020 169.99 615.7045 PAI-M 41316 26/07/2023 10/06/2020 Books
An institution deemed to be a University Estd. Vide Sec.3 of the UGC
Act,1956 under notification # F.12-23/63.U-2 of Jun 18,1964

© 2015 BITS-Library, BITS-Hyderabad, India.